Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)
NCT:NCT07754318 · RECRUITING
广告
NCT编号NCT07754318
状态RECRUITING
开始日期2026-08-26
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated
简要摘要
To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。